Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2019/0002515 NOVEL GENERATION OF ANTIGEN-SPECIFIC TCRS
The present invention contemplates methods for the generation of human antigen-specific T lymphocytes. The methods employ MHC class-II targeting signals fused...
2019/0002514 PEPTIDES BINDING TO BFL-1
This disclosure features stapled peptide inhibitors (e.g., cysteine-reactive stapled peptides) of the anti-apoptotic protein, BFL-1, and methods of using same...
2019/0002513 HLA-A24 AGONIST EPITOPES OF MUC1-C ONCOPROTEIN AND COMPOSITIONS AND METHODS OF USE
The invention provides a human cytotoxic T lymphocyte (CTL) agonist epitope from the C-terminal subunit of mucin 1 (MUC1-C), which can be used as a peptide,...
2019/0002512 GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
The invention provides formulations and methods for ameliorating symptoms associated with metabolic disorders, such as cachexia, hypoglycemia, obesity,...
2019/0002511 NOVEL THROMBIN INHIBITORS
The present invention provides isolated peptides, variants and fragments thereof that are capable of binding with a high level of specificity to thrombin and...
2019/0002510 COMPOSITIONS AND METHODS FOR FABRICATING SYNTHETIC DRAGLINE SPIDER SILK
Compositions comprising a mixture of proteins derived from MaSP, nucleic acids encoding same and method for the preparation of synthetic dragline spider silk...
2019/0002509 SITE-SPECIFIC BIO-CONJUGATION METHODS AND COMPOSITIONS USEFUL FOR NANOPORE SYSTEMS
The present disclosure relates to relates methods and associated compositions that provide fast, efficient site-selective conjugation of a protein, such as the...
2019/0002508 PORE-MODIFIED GRAM-NEGATIVE BACTERIA AND USES THEREOF
Mutants of Gram-negative bacteria having outer membranes comprising modified OrbA nanopores absent an N-terminal plug domain are disclosed. The modified OrbA...
2019/0002507 THERAPEUTIC COMPOSITIONS AND METHODS FOR ANTIBODY AND FC-CONTAINING TARGETING MOLECULE-BASED TARGETED DELIVERY...
The present application relates to the use of bacterial minicells as targeted delivery agents in vivo and in vitro. Described herein are genetically engineered...
2019/0002506 STABILIZED PEPTIDES FOR COVALENT BINDING TO TARGET PROTEIN
Provided herein is a platform technology for designing stabilized peptides that covalently bind their target protein and thereby inhibit the activity of the...
2019/0002505 NOVEL PEPTIDE AND USE THEREOF
The invention provides a peptide and an immunostimulant or hair grower containing the peptide as an active ingredient, as well as a method for hair growth or...
2019/0002504 IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC
A method of treating a patient who has glioblastoma and/or gastric cancer includes administering to said patient a composition containing a population of...
2019/0002503 ANALOGUES OF HEPCIDIN MIMETICS WITH IMPROVED IN VIVO HALF LIVES
The present invention provides hepcidin analogues with improved in vivo half-lives, and related pharmaceutical compositions and methods of use thereof.
2019/0002502 Cell-Permeable Inhibitory Agent and Methods of Use Thereof in Treatment of Cognitive and Mood Disorders
The present application provides an inhibitory compound, such as a peptide, and methods for using the inhibitory compound in the treatment, diagnosis or...
2019/0002501 ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME
The invention provides processes of purifying a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-251 described...
2019/0002500 NOVEL a4B7 PEPTIDE DIMER ANTAGONISTS
The invention relates to disulfide-rich dimer molecules which inhibit binding of .alpha.4.beta.7 to the mucosal addressin cell adhesion molecule (MAdCAM) in...
2019/0002499 PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES
The present invention pertains to peptides and peptide-containing complexes/nanoparticles that are useful for stabilizing and delivering cargo molecules such...
2019/0002498 TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH PROTEASE INHIBITORY ACTIVITY
Template-fixed .beta.-hairpin peptidomimetics of the general formulae ##STR00001## wherein Z is a chain of 11 .alpha.-amino acid residues which, depending on...
2019/0002496 Dipeptide Comprising a Non-Proteogenic Amino Acid
Described is a dipeptide comprising a non-proteogenic amino acid, methods of making such and methods of using said dipeptide in a process of making a...
2019/0002495 NON-CHROMATOGRAPHIC SEPARATION OF POLYPEPTIDES USING THE COMBINATION OF A STERIC EXCLUSION AGENT AND A CHARGE...
The present invention relates to methods of separating polypeptides of interest from contaminants, including DNA and undesired polypeptides, in a common fluid...
2019/0002494 METHODS FOR THE SITE-SELECTIVE COUPLING OF A FIRST AGENT TO A SECOND AGENT
The present invention relates to a method for site-selective coupling of a first agent to a second agent, comprising the steps of: contacting a first agent...
2019/0002493 3-DESOXY DERIVATIVE AND PHARMACEUTICAL COMPOSITIONS THEREOF
The present application provides Compound 1: ##STR00001## or a pharmaceutically acceptable salt or amino acid conjugate thereof. The present invention relates to...
2019/0002492 DERIVATIVES OF ALLOPREGNANOLONE AND OF EPIALLOPREGNANOLONE AND USES THEREOF FOR TREATING A NEUROPATHOLOGICAL...
The present invention relates to novel neurosteroids, especially derivatives of allopregnanolone and of epiallopregnanolone of formula (I) and the uses thereof...
2019/0002491 FLUORESCENT DYES AND METHODS OF USE THEREOF
Provided are methods for labeling target molecules, such as nucleic acids, with fluorescent dye compounds having the formula ##STR00001## One method embodiment...
2019/0002490 Novel compositions and methods for depolymerizing lignin using a chelator-mediated Fenton reaction
The present invention provides for a method to depolymerize a lignin comprising: (a) mixing a lignin, a chelator, and FeCl.sub.3 to produce a first solution,...
2019/0002489 LIPID-BASED PLATINUM COMPOUNDS AND NANOPARTICLES
The present disclosure is in relation to the field of nanotechnology and cancer therapeutics. In particular, the present disclosure relates to platinum based...
2019/0002488 LIGHT-EMITTING COMPOUND
A compound of formula (I): wherein M is a transition metal; Ar.sup.1 is a 5 or 6 membered heteroaryl ring or a polycyclic heteroaromatic group; Ar.sup.2 is a...
2019/0002487 SYNTHESIS OF HYPERVALENT IODINE REAGENTS WITH DIOXYGEN
Methods of synthesis of hypervalent iodine reagents and methods for oxidation of organic compounds are disclosed.
2019/0002486 PROCESSES FOR PRODUCING ORGANOPHOSPHOROUS COMPOUNDS
The present invention relates to processes for producing organophosporous compositions having low acid content as well as processes for reprocessing partially...
2019/0002485 PROCESSES FOR PRODUCING ORGANOPHOSPHOROUS COMPOUNDS
The present invention relates to processes for producing organophosporous compositions having low acid content as well as processes for reprocessing partially...
2019/0002484 DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE
The present invention provides a compound having the structure of Formula (I) or a pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof, for...
2019/0002483 NOVEL CRYSTALLINE FORMS
Preparation and characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in...
2019/0002482 NOVEL BISPHOSPHONIC ACID COMPOUND
It is intended to provide a novel bisphosphonic acid compound or a salt thereof which shows a remarkable inhibitory effect on ectopic calcification, and a...
2019/0002481 METHODS FOR SYNTHESIZING METAL MESOPORPHYRINS
Embodiments describe methods of synthesizing metal mesoporphyrin compounds. In embodiments, a metal mesoporphyrin compound may be formed by hemin...
2019/0002480 Silane-Containing Heterocyclic Compounds and Methods of Use Thereof for the Treatment of Viral Diseases
The present invention relates to novel Silane-Containing Heterocyclic Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, A',...
2019/0002479 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: ##STR00001## which inhibit...
2019/0002478 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: ##STR00001## which inhibit...
2019/0002477 ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
Disclosed herein are compounds, pharmaceutical compositions, and related methods for the treatment of viral infection, including RNA viral infection in...
2019/0002476 BACE1 INHIBITORS
The present invention provides a compound of formula I, having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and...
2019/0002475 OXA-DIAZASPIRO COMPOUNDS HAVING ACTIVITY AGAINST PAIN
The present invention relates to oxa-diazaspiro compounds having pharmacological activity towards the sigma (.sigma.) receptor, to processes of preparation of...
2019/0002474 COMMERCIALLY VIABLE SYNTHESIS OF CANTHARIDIN AND BIOACTIVE CANTHARIDIN DERIVATIVES
The present disclosure provides methods for synthesizing cantharidin and cantharidin derivatives.
2019/0002473 COMPOUNDS FOR TREATMENT OF PAIN
The aspects of the disclosed embodiments are directed to novel compounds, formulations containing said compounds or pharmaceutically acceptable salts thereof...
2019/0002472 IMMUNOREGULATORY AGENTS
Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such...
2019/0002471 Crystalline Form Of Ticagrelor
A crystalline form of ticagrelor, designated as Form-AM, has a defined interplanar spacing as illustrated by FIG. 1.
2019/0002470 BICYCLIC AZAHETEROCYCLOBENZYLAMINES AS PI3K INHIBITORS
The present invention provides bicyclic azaheterocyclobenzylamines of Formula I: ##STR00001## wherein the variables are defined herein, that modulate the...
2019/0002469 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ORGANIC LIGHT EMITTING DIODES
Compounds of formula (I) and their use in electronic devices, especially electroluminescent devices: (I) wherein at least two of the substituents R.sup.1 and...
2019/0002468 CRYSTALLINE FORMS OF IBRUTINIB
The present invention relates to crystalline forms of ibrutinib, designated as Form S1, Form S2, Form S3, Form S4, and an amorphous form, designated as Form...
2019/0002467 NOVEL FUSED PYRIMIDINONE AND TRIAZINONE DERIVATIVES CONTAINING BRIDGED NITROGEN, THEIR PROCESS OF PREPARATION...
The present invention concerns novel fused pyrimidinone and triazinone derivatives containing bridged nitrogen, their process of preparation and their use as...
2019/0002466 PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL, PYRROLO[2,3-B]PYRIDINYL ACRYLAMIDES AND EPOXIDES THEREOF
The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl, and pyrrolo[2,3-b]pyridinyl acrylamides, epoxides,...
2019/0002465 COMPOUNDS AS MODULATORS OF ROR GAMMA
The present invention encompasses compounds of the formula (I) ##STR00001## wherein the variables are defined herein which are suitable for the modulation of...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.